Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nonprescription Treatment Options.
Edwards T, Felix K, Francois S, Cardwell L, Rice Z. Edwards T, et al. Among authors: rice z. Adv Exp Med Biol. 2024;1447:151-167. doi: 10.1007/978-3-031-54513-9_14. Adv Exp Med Biol. 2024. PMID: 38724792
A frameshift variant in the melanophilin gene is associated with loss of pigment from shed skin in ball pythons ( Python regius ).
Lederer I, Shahid B, Dao U, Brogdon A, Byrtus H, Delva M, Deva O, Hatfield P, Hertz M, Justice J, Mavor S, Pilbeam E, Rice Z, Simpson A, Temar H, Wynn R, Xhangolli J, Graves C, Seidel H. Lederer I, et al. Among authors: rice z. MicroPubl Biol. 2023 Aug 9;2023:10.17912/micropub.biology.000896. doi: 10.17912/micropub.biology.000896. eCollection 2023. MicroPubl Biol. 2023. PMID: 37637270 Free PMC article.
Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary.
Reich K, Thyssen JP, Blauvelt A, Eyerich K, Soong W, Rice ZP, Hong HC, Katoh N, Valenzuela F, DiBonaventura M, Bratt TA, Zhang F, Clibborn C, Rojo R, Valdez H, Kerkmann U. Reich K, et al. Among authors: rice zp. Immunotherapy. 2023 Sep;15(13):975-980. doi: 10.2217/imt-2022-0306. Epub 2023 May 31. Immunotherapy. 2023. PMID: 37254941 Free article. Review.
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial.
Reich K, Thyssen JP, Blauvelt A, Eyerich K, Soong W, Rice ZP, Hong HC, Katoh N, Valenzuela F, DiBonaventura M, Bratt TA, Zhang F, Clibborn C, Rojo R, Valdez H, Kerkmann U. Reich K, et al. Among authors: rice zp. Lancet. 2022 Jul 23;400(10348):273-282. doi: 10.1016/S0140-6736(22)01199-0. Lancet. 2022. PMID: 35871814 Clinical Trial.
Non-Prescription Treatment Options.
François S, Felix K, Cardwell L, Edwards T, Rice Z. François S, et al. Among authors: rice z. Adv Exp Med Biol. 2017;1027:121-137. doi: 10.1007/978-3-319-64804-0_11. Adv Exp Med Biol. 2017. PMID: 29063436 Review.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
20 results